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Abstract 
Background: The changes in the rate of leukocytes are simple, rapid and hopeful inflammation parameters in many 
diseases. Despite the close relationship between spondylodiscitis and inflammation, the roles of leukocyte subtypes 
in spondylodiscitis have not been previously investigated. 
Objective: To evaluate the value of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and lymphocyte-
to-monocyte ratio in predicting abscess and etiology in spondylodiscitis. 
Materials and methods: A total of 121 medical records of patients were analyzed retrospectively. The data were 
obtained from hospital records. The neutrophil-to-lymphocyte, platelet-to-lymphocyte and lymphocyte-to-monocyte 
ratios were calculated using neutrophil, lymphocyte, monocyte and platelet levels in complete blood count 
measurements. Patients’ clinical data, and their neutrophil-to-lymphocyte, platelet-to-lymphocyte and lymphocyte-
to-monocyte ratio values, were analyzed statistically. 
Results: A total of 121 medical records were evaluated; the male-to-female ratio was 1:1.2 and mean age was 
56.1±16.6 years at the time of diagnosis. The lymphocyte-to-monocyte ratio was lower in patients with abscesses 
than patients with no abscesses (p=0.040). The ‘area under the curve’ value for lymphocyte-to-monocyte ratio was 
0.626, with a cut-off point of ≤3.7 in predicting abscess in patients with spondylodiscitis. The mean neutrophil-to-
lymphocyte ratio was higher and lymphocyte-to-monocyte ratio was lower in pyogenic spondylodiscitis compared 
to granulomatous spondylodiscitis (p=0.001 and p=0.038). The ‘area under the curve’ values for the neutrophil-to-
lymphocyte ratio and the lymphocyte-to-monocyte ratio were 0.717 and 0.680, respectively, with cut-off points of 
≥4.9 and <2.7, respectively, in discriminating pyogenic spondylodiscitis from granulomatous spondylodiscitis.  
Conclusions: The neutrophil-to-lymphocyte ratio and lymphocyte-to-monocyte ratio are simple, broadly available 
and cost-effective parameters, and may be useful in the differential diagnosis of infectious spondylodiscitis. [Ethiop. 
J. Health Dev. 2020; 34(2):144-121] 
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Introduction  
Spinal infections describe infections of the vertebral 
body, intervertebral discs, and/or paraspinal tissue (1). 
Vertebral body infection (vertebral osteomyelitis) can 
affect both vertebrae and intervertebral discs and is 
termed spondylodiscitis. Although isolated discitis is 
usually seen in childhood, vertebral osteomyelitis and 
discitis are thought to be different processes of the same 
disease (2,3). The global incidence of spondylodiscitis 
is reported as 2.4 cases per 100,000 per year, and 
spondylodiscitis accounts for only 2-7% of all 
osteomyelitis cases (1-4). However, incidence of 
spondylodiscitis has been raised in recent reports 
according to aging of the population, increased number 
of intravenous drug addiction, immunosuppression by 
malignancy or acquired immunodeficiency syndrome 
(AIDS), frequency of interventional procedures and also 
associated with the widespread use of magnetic 
resonance imaging (MRI) depending on the sensitivity 
of clinicians (2,3). Therefore, these infections have 
become an important clinical problem for public health 
that requires a serious medical and surgical approach. 
 
Etiologically, spinal infections are classified as 
pyogenic (caused by bacteria), granulomatous (caused 
by Mycobacterium tuberculosis, Brucella spp. or fungi) 
and parasitic spondylodiscitis (1). Brucella and 
tuberculosis, which cause granulomatous 
spondylodiscitis, is an important public health problem, 
especially in developing countries. Spinal infection may 
develop by haematogenous spread from another 
infection site, direct external inoculation, or contiguous 
spread from adjacent infected tissues (5). Inflammation 
may remain localized in these infections or the 
progression of infection may cause abscess formation 
(1-3,5). Estimating the etiological agent and appropriate 
treatment of spondylodiscitis are important because 
treatment delay may cause complications, including 
abscess formation, and because delay is associated with 
unresponsiveness to treatment and increased mortality 
(1). Spinal infection can be diagnosed by physical 
examination, laboratory and imaging findings. 
Pathogenic microorganisms can be isolated by 
microbiological culture, but there is a delay in diagnosis 
because biopsy (or tissue sampling) is difficult, time-
consuming and involves invasive techniques (1-4). In 
addition, culture studies do not always give positive 
results (1). MRI is the most reliable method of 
diagnosing spondylodiscitis and in evaluating spinal 
and/or paraspinal abscess formation (3). Nevertheless, 
there are disadvantages to MRI: it is expensive, time-
consuming, and not a readily accessible technique at all 
health centers. 
 
Chronic inflammation plays a major role in the 
pathogenesis of spondylodiscitis and its complications 
(5,6). Leukocyte counts, erythrocyte sedimentation rate 
(ESR) and C-reactive protein (CRP) are routinely 
available laboratory biomarkers of inflammation. The 
circulating neutrophil, monocyte, lymphocyte and 
platelet distributions vary in inflammatory process (6,7). 
Recent studies highlight that changes in the rate of 
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leukocytes are simple and rapid inflammation 
parameters in many diseases (6-8). Despite the close 
relationship between spondylodiscitis and 
inflammation, the roles of leukocyte subtypes in 
spondylodiscitis have not been previously investigated. 
To the best of our knowledge, this is the first study to 
evaluate the circulating neutrophil, lymphocyte, 
monocyte and platelet distribution in spondylodiscitis. 
In our study, we demonstrate the value of neutrophil-to-
lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio 
(LMR) and platelet-to-lymphocyte ratio (PLR) in 
predicting abscess and etiology in spondylodiscitis. 
 
Materials and methods 
Patients: A total of 121 patients diagnosed with spinal 
infection were analyzed retrospectively from January 
2010 to February 2019 in a tertiary referral care center, 
Izmir Katip Celebi University Ataturk Training and 
Research Hospital, Turkey. The study protocol was 
approved by our local ethics committee (March 27, 
2019, Approval Number: 162). Patients were excluded 
from the study in the presence of any of the following 
conditions: age less than 16 years, non-infectious 
spondylodiscitis, other foci of infection, pregnancy, and 
previous antibiotic use within the past two months. 
Demographic factors, comorbidities (including diabetes 
mellitus, hypertension, chronic kidney disease, chronic 
cardiac disease, malignancy and use of corticosteroids), 
site of infection, clinical findings, length of hospital 
stay, presence of abscess, neurological deficit (sensory 
or motor deficit), laboratory parameters, type and 
duration of treatment and recurrence rates were 
recorded. The etiologic agents (pyogenic or 
granulomatous spondylodiscitis) and presence of 
abscess were used as response variables. 
 
Assessment of laboratory findings: Spinal infection 
was diagnosed by clinical, laboratory and radiological 
findings. Infection markers – such as white blood cell 
(WBC) counts, CRP, ESR and procalcitonin (PCT) – 
were analyzed as laboratory tests. These biomarkers 
were evaluated at the time of hospital admission. The 
NLR, LMR and PLR values were obtained using 
neutrophil, monocyte, lymphocyte and platelet levels 
from complete blood count measurements. Blood, 
sputum and urine cultures were taken from patients, if 
necessary. Microbiological cultures were performed on 
obtained tissue samples if the patients had undergone 
biopsy, drainage or surgery.  
 
Assessment of clinical findings: We analyzed two 
different conditions separately: 1. patients were divided 
into two groups according to the presence of abscess 
(abscess [+] and abscess [-]) and the clinical and 
laboratory findings of two groups were compared; 2: 
patients were divided into two groups on the basis of 
pyogenic spondylodiscitis and granulomatous 
spondylodiscitis, and the clinical and laboratory 
findings of these two groups were compared. Vertebral 
bodies, paravertebral and epidural areas, nerve roots, 
spinal canal and abscess formation were evaluated in 
MRI. The diagnosis of abscess formation was based on 
the findings of MRI. MRI data were available for all 
patients. The diagnosis of pyogenic or granulomatous 
spondylodiscitis was determined according to the 
etiological agent obtained from clinical samples. 
Isolation of Mycobacterium tuberculosis or Brucella 
spp. from clinical specimens was defined as 
granulomatous spondylodiscitis. Bacterial isolation 
from clinical specimens was defined as pyogenic 
spondylodiscitis. If the causative microorganism could 
not be isolated in culture, the clinical response to 
empirical antibiotherapy was accepted as pyogenic 
spondylodiscitis. 
 
Treatment and follow-up of patients: All patients were 
evaluated by multidisciplinary teams, including 
infectious disease specialists, surgeons and radiologists, 
in terms of treatment and follow-up. A conservative 
approach was the first choice of treatment. Biopsy was 
performed on the differential diagnosis of suspicious 
lesions. Initial empirical antimicrobial treatment was 
revised according to the culture results and antibiotic 
susceptibility testing. Antimicrobial treatment was 
administered for at least six weeks. The duration of 
treatment was individualized based on the clinical, 
laboratory and radiological response for each patient. 
Surgical intervention was performed in the presence of 
medical treatment failure, epidural abscess, neurological 
deficit or spinal instability/deformity. After the end of 
treatment, receiving a second course of antimicrobial 
therapy due to resumption of symptoms (fever, back 
pain, tenderness by palpation of the spinal process), 
elevation of infection markers such as WBC, CRP, ESR 
and PCT, and reappearance of new lesions on MRI, were 
defined as recurrence. The disappearance of all signs 
and symptoms, except for permanent neurological 
sequelae in the subsequent six months since the end of 
antibiotics, was defined as recovery. 
 
Statistical analysis: All statistical analyses were 
performed with SPSS software version 24. Descriptive 
analyses were presented using means and standard 
deviations for normally distributed variables. Student’s 
t-test was performed to compare the groups. The chi-
square test was applied for the test of association levels 
of two categorical variables. The sensitivity, specificity 
values and receiver operating characteristic curve 
(ROC) analysis methods were examined using MedCalc 
version 14 (MedCalc Software). A p-value of less than 
0.05 was considered statistically significant. 
 
Results  
Study population: A total of 121 patients were 
evaluated; the male:female ratio was 1:1.2 (66 men, 55 
women) and mean age was 56.1±16.6 years (range 16-
86 years) at the time of diagnosis. Forty-five patients 
(37.2%) had least one comorbid disease. The most 
common comorbidity was diabetes mellitus (22.3%), 
followed by hypertension (19%), chronic kidney disease 
(14%), coronary artery disease (7.4%) and malignancy 
(3.3%). Although comorbidities did not differ between 
patients with or without abscesses, the prevalence of 
diabetes mellitus, hypertension and chronic kidney 
disease was higher in pyogenic spondylodiscitis than 
granulomatous spondylodiscitis (p=0.028, p=0.001 and 
p<0.001, respectively) (Table 1)
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Table 1: Comparison of the abscess [+] and abscess [-] patients; and comparison of the pyogenic spondylodiscitis and granulomatous spondylodiscitis in terms of 























Age (mean±SD) 56.1±16.6 54.4±17.1 58.1±15.8 0.224 59.9±12.8 53.5±18.3 0.034 
Male (n, %) 66 (54.6%) 36 (55.4%) 30 (53.6%) 0.857 24 (49%) 42 (58.3%) 0.355 
Comorbidities    p**   p** 
Diabetes mellitus 27 (22.3%) 15 (23.1%) 12 (21.4%) >0.999 16 (32.7%) 11 (15.3%) 0.028 
Hypertension 23 (19%) 16 (24.6%) 7 (12.5%) 0.107 17 (34.7%) 6 (8.3%) 0.001 
Chronic kidney disease 17 (14%) 11 (16.9%) 6 (10.7%) 0.434 16 (32.7%) 1 (1.4%) <0.001 
Coronary artery disease 9 (7.4%) 5 (7.7%) 4 (7.1%) >0.999 6 (12.2%) 3 (4.2%) 0.156 
Malignancy 4 (3.3%) 4 (6.2%) 0 - 3 (6.1%) 1 (1.4%) 0.302 
Laboratory results    p*   p* 
Hemoglobin (g/dL ) 12±1.9 11.9±2 12.2±1.9 0.429 11.4±2 12.4±1.8 0.007 
WBC (K/uL) 8765.9±3587.5 8952.7±3758.4 8552.7±3402.9 0.545 10463.7±4466.7 7634±2261.9 <0.001 
Neutrophil (K/uL) 6112.6±3446.6 6279.5±3532.9 5921.8±3366.9 0.573 7761.8±4280.2 5013.1±2172.1 <0.001 
Lymphocyte (K/uL) 1896.4±741.1 1856.3±843.8 1942.9±604.7 0.524 1797.8±846.8 1963.5±657.4 0.252 
Monocyte (K/uL) 607.7±329.2 660.1±404.8 546.9±196.7 0.049 722.9±453.5 529.3±169.5 0.006 
Platelet (K/uL) 309289.3±124723.7 317046.1±124343.3 300285.7±125679.9 0.463 322428.6±142694.2 300347.2±111022.5 0.341 
MPV (fl) 9.2±1.2 9.2±1.2 9.1±1.2 0.521 9.5±1.1 8.9±1.2 0.016 
AST (U/L) 24.9±17.9 24.9±15.9 25±20.1 0.986 21±12.6 27.6±20.4 0.047 
ALT (U/L) 29.2±30.5 32.9±36.2 24.9±21.6 0.137 21.2±19.9 34.7±35.1 0.017 
BUN (mg/dl) 19.6±13.2 20.1±15.3 19.1±10.3 0.687 24.2±17.6 16.6±7.6 0.006 
Serum creatinine 
(mg/dl) 1.2±1.5 1.2±1.5 1.3±1.6 0.791 1.8±2.2 0.8±0.6 0.004 
ESR (mm/h) 58.8±30.8 62.3±29.4 54.7±32.2 0.185 65.6±32.7 54.3±28.9 0.052 
CRP (mg/dl) 6.6±7.7 8.4±9.1 4.5±5.3 0.006 8.8±9.7 5.2±5.7 0.023 
PCT (ng/ml) 0.2±0.4 0.2±0.2 0.3±0.5 0.523 0.3±0.6 0.2±0.2 0.610 
NLR 4.3±4.7 4.7±5.4 3.7±3.8 0.256 6.2±6.1 2.9±2.7 0.001 
PLR 190.8±109.2 204.6±110.9 174.9±106 0.136 209.8±103.9 177.9±111.5 0.115 
LMR 3.6±2 3.3±2 4±2 0.040 3.2±2.4 4±1.6 0.038 
 
SD: standard deviation, WBC: white blood cell, MPV: mean platelet volume, AST: aspartate aminotransferase, ALT: alanine aminotransferase, BUN: blood urea nitrogen,  
ESR: erythrocyte sedimentation rate, CRP: C-reactive protein, PCT: procalcitonin, NLR: neutrophil-to-lymphocyte ratio, PLR: platelet-to-lymphocyte ratio, LMR:  
lymphocyte-to-monocyte ratio * Student’s t-test was used for the analysis; ** Chi-square test was used for the analysis 
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The most common symptom was back pain (98.3%). 
Other symptoms were fever (24.8%), neurological 
deficit (20.7%) and tenderness on spinous process 
(7.4%). Anatomic site of infection was as follows: 
cervical (7.4%), thoracal (14%), lumbar (48.8%), 
thoracolumbar (14.9%), lumbosacral (14%) and 
cervicolumbar (0.8%).  
 
Sixty-five (53.7%) patients had abscesses and 56 
(46.3%) patients had no abscesses, according to MRI 
findings. Forty-nine (40.5%) patients had pyogenic 
spondylodiscitis and 72 (59.5%) patients had 
granulomatous spondylodiscitis. Of the patients with 
pyogenic spondylodiscitis, 44 cases had spontaneous 
spondylodiscitis and five had post-operative 
spondylodiscitis. Of the patients with granulomatous 
spondylodiscitis, 59 had brucellar spondylodiscitis and 
13 had tuberculous spondylodiscitis. 
 
Laboratory findings: Twenty-three patients (19%) had 
leukocytosis (>11,000 cells/mm³). The increased ESR 
value (>30 mm/h) was found in 91 (75.2%) patients. 
There were 98 (81%) patients with CRP> 1 mg/dl.  
 
Compared to patients with no abscesses, the mean 
monocyte and CRP levels were higher, and LMR was 
lower, in patients with abscesses (p=0.049, p=0.006 and 
p=0.040, respectively). Other laboratory values did not 
differ between patients with and without abscesses in 
spondylodiscitis (Table 1).  
 
The mean WBC, neutrophil, monocyte, MPV, aspartate 
aminotransferase (AST), alanine aminotransferase 
(ALT), blood urea nitrogen (BUN), serum creatinine, 
CRP and NLR levels were higher in pyogenic 
spondylodiscitis than granulomatous spondylodiscitis 
(p<0.001, p<0.001, p=0.006, p=0.016, p=0.047, 
p=0.017, p=0.006, p=0.004, p=0.023 and p=0.001, 
respectively). In addition, mean hemoglobin and LMR 
levels were lower in pyogenic spondylodiscitis 
compared to granulomatous spondylodiscitis (p=0.007 
and p=0.038, respectively) (Table 1). 
 
Blood culture was obtained from 113 patients and blood 
culture positivity was detected in 25 patients. Tissue 
culture positivity was detected in 18 of 113 patients. 
Both blood and tissue cultures were positive in one 
patient. The etiologic agent was detected in 42 patients. 
The isolated microorganisms were as follows: Brucella 
spp. (19), Staphylococcus aureus (12), Mycobacterium 
tuberculosis (7), Escherichia coli(2), Pseudomonas 
aeruginosa (1), coagulase-negative staphylococci (1) 
and Achromobacter spp. (1). Eleven isolates of 
Staphylococcus aureus were susceptible to methicillin, 
while methicillin resistance was detected in one strain. 
Tissue culture positivity was higher in patients with 
abscesses than patients who had no abscesses (p=0.011) 
(Table 1). 
 
Diagnostic values of NLR, PLR and LMR: The mean 
NLR and PLR levels were higher in patients with 
abscesses than in patients with no abscesses, but the 
difference was not statistically significant (p=0.256 and 
p=0.136, respectively). The mean LMR was lower in 
patients with abscesses compared to the patients with no 
abscesses (3.3±2 and 4±2, respectively; p=0.040). The 
area under the curve (AUC) value for LMR was 0.626 
(95% CI: 0.525-0.726) with the cut-off point of ≤3.7 in 
predicting abscesses in patients with spondylodiscitis. 
Applying ROC curve at the cut-off point of 3.7, LMR 
yielded 70.3% sensitivity and 57.1% specificity (Table 
2 and Figure 1). 
 
Table 2: Diagnostic value of NLR, PLR and LMR in predicting abscess or etiology in 
spondylodiscitis 
 









Presence of abscess formation 
NLR 0.562 0.236 >3.4 46.9 73.2 1.7 0.7 66.7 54.7 
PLR 0.602 0.048 >186.5 47.7 73.2 1.8 0.7 67.4 54.7 
LMR 0.626 0.014 ≤3.7 70.3 57.1 1.6 0.5 65.2 62.7 
Pyogenic spondylodiscitis 
NLR 0.717 <0.001 ≥4.9 91.6 48.9 1.8 0.2 72.2 80 
PLR 0.605 0.052 ≥197.7 79.2 53.1 1.7 0.4 71.2 63.4 
LMR 0.680 <0.001 <2.7 81.9 54.2 1.8 0.3 72.8 66.7 
NLR: neutrophil-to-lymphocyte ratio, PLR: platelet-to-lymphocyte ratio, LMR: lymphocyte-to-monocyte 
ratio, AUC: area under the ROC curve, LR: likelihood ratio, PV: predictive value 
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Figure 1: Receiver operating characteristic (ROC) curve analysis for various cut-off levels of NLR, 
PLR and LMR in predicting abscess in spondylodiscitis 
 
The mean NLR level was higher in patients with 
pyogenic spondylodiscitis compared to patients with 
granulomatous spondylodiscitis (6.2±6.1 and 2.9±2.7, 
respectively; p=0.001). In contrast, LMR was lower in 
pyogenic spondylodiscitis than granulomatous 
spondylodiscitis (3.2±2.4 and 4±1.6, respectively; 
p=0.038). The mean PLR level did not differ between 
pyogenic and granulomatous spondylodiscitis 
(209.8±103.9 and 177.9±111.5, respectively; p=0.115). 
The AUC value was 0.717 for NLR and 0.680 for LMR. 
Both NLR and LMR showed high sensitivities (91.6% 
and 81.9%) in discriminating pyogenic spondylodiscitis 
from granulomatous spondylodiscitis (Table 2 and 




Figure 2: Receiver operating characteristic (ROC) curve analysis for various cut-off levels of NLR, 
PLR and LMR in discriminating pyogenic and granulomatous spondylodiscitis 
 
Treatment and follow-up of patients: Conservative 
antibiotic therapy was applied in 90 (74.4%) patients. In 
addition, surgical treatment was performed on 31 
(25.6%) patients. Recurrence was detected in 12 of 98 
patients for whom data were available. Eight of these 
patients had medical treatment while four of them had 
undergone surgery. The recurrence rates were similar 
between the treatment modalities of patients (medical 
and surgical) (p=0.223). There was no significant 
difference in NLR, PLR and LMR values between the 
patients with and without recurrence (p=0.891, p=0.426 
and p=0.277, respectively). 
 
Discussion 
Inflammation is the non-specific response of the 
organism to exogenous or endogenous stimuli (9). The 
classical initiators of inflammation are tissue injury and 
infection. However, it can be triggered by various 
physiological and pathological processes and the 
response to all these stimuli is similar (10). In the first 
instance, an acute inflammatory response is initiated by 
receptors of the innate immune system in response to a 
stimulus (9,10). Inflammatory mediators are released by 
the macrophages and mast cells during this initial 
recognition phase (9-11). As a result, vascular 
endothelial damage occurs, and plasma proteins and 
platelets reach the extravascular space (10). Platelets are 
activated by contact with collagen and produce 
inflammatory mediators (9). Leukocytes and plasma 
proteins are directed to the target tissue through the 
influence of these mediators (11). If the acute 
inflammatory response is effective, the repair phase 
begins. Through the anti-inflammatory mediators, 
macrophage and monocyte activations are promoted and 
tissue remodeling begins (12). If the acute inflammatory 
response is insufficient, the neutrophils are replaced by 
macrophages and lymphocytes, and chronic 
inflammation occurs (13). Therefore, we believe that the 
cell lines that control the immune system in chronic 
inflammation are best reflected by monocyte and 
lymphocyte levels. In our study, the fact that LMR was 
found useful in the differential diagnosis of infectious 
spondylodiscitis also supports our argument. 
 
Recently, there has been an intense interest in the role of 
inflammation markers in various diseases such as 
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cancer, metabolic diseases, ischemic heart diseases, 
infectious diseases and other medical conditions (14). 
Current studies demonstrate that NLR, LMR and PLR 
may be useful in many diseases because of their ability 
to predict systemic inflammation (7,8,14-16). These 
studies are based on changes in neutrophil, lymphocyte, 
monocyte and platelet counts, depending on the 
physiological responses to stimuli (15,16). In our 
literature review, we observed that conflicting results 
have been obtained about the relationship between these 
biomarkers and infectious diseases (17-26). Naess and 
colleagues showed that NLR and MLR were higher in 
bacterial infection compared to viral infection (17), and 
that NLR and MLR were significantly higher in 
bacterial infection compared to non-infectious 
conditions (12.23±0.98 and 5.02±0.67; p<0.001 for 
NLR; and 2.41±0.75 and 5.02±0.67; p=0.010 for MLR) 
in patients hospitalized for fever (17). In addition, they 
indicated that patients with septicemia had significantly 
higher NLR compared to patients with other bacterial 
infections with fever for less than one week (23.17±4.40 
and 10.79±2.42; p=0.006). In another study (18), 172 
HBV-infected patients and 40 healthy controls were 
examined; PLR levels were lower in HBV-related 
cirrhotic patients (56±21; p<0.001). In addition, higher 
NLR levels were found to be useful in predicting disease 
progression in chronic HBV infection. HBV-related 
decompensated cirrhosis patients had a significantly 
higher mean NLR (4.0±1.1; p<0.001). In the logistic 
regression prediction model, a predictive probability 
cut-off of 0.392 had the highest sensitivity and 
specificity (sensitivity, 91.2%; specificity, 84.0%) in 
distinguishing between both HBV-related compensated 
cirrhosis and HBV-active carrier patients. A NLR cut-
off value of 2.94 had the highest sensitivity and 
specificity (sensitivity, 81.8%; specificity, 88.2%) in 
distinguishing between HBV-related decompensated 
cirrhosis and HBV-related compensated cirrhosis 
patients. Meng et al. demonstrated that lower PLR levels 
were closely related to the virological response and 
disease severity in patients with chronic hepatitis C virus 
(HCV) infection (19). In this study, 120 HCV-infected 
patients and 40 healthy controls were analyzed. The 
HCV-related cirrhosis group and HCV-related 
hepatocellular carcinoma group were found to have 
lower PLRs (61±31 and 51±23) than the healthy 
controls (115±23). The PLR of the HCV cleared group 
(154±85) was significantly higher than that of the HCV 
untreated group and HCV uncleared group (90±28 and 
88±40, respectively). ROC curve analysis for the PLR 
showed an AUC of 0.772 (95% CI; 0.674–0.869, 
p<0.001); for NLR, the AUC was 0.612 (95% CI; 
0.495–0.730, p=0.063). Furthermore, an increasing PLR 
in chronic hepatitis C patients indicated a good 
virological response, and a stable PLR or a downward 
trend in PLR could predict no rapid virological response 
being achieved by week 4, and even no sustained 
virological response by week 72.  
To our knowledge, this is the first study to evaluate the 
distribution of circulating neutrophil, lymphocyte, 
monocyte and platelet parameters in spondylodiscitis. In 
our study, LMR was found useful in predicting abscess 
in spondylodiscitis. The mean LMR was found to be 
lower in patients with abscesses compared to the 
patients with no abscesses (3.3±2 and 4±2, respectively; 
p=0.040). In addition, both NLR and LMR were found 
to be significant in discriminating pyogenic 
spondylodiscitis from granulomatous spondylodiscitis. 
The mean NLR level was higher in patients with 
pyogenic spondylodiscitis compared to patients with 
granulomatous spondylodiscitis (6.2±6.1 and 2.9±2.7, 
respectively; p=0.001). In contrast, LMR was lower in 
pyogenic spondylodiscitis than granulomatous 
spondylodiscitis (3.2±2.4 and 4±1.6, respectively; 
p=0.038). These parameters may be good as a diagnostic 
tool in spondylodiscitis. 
 
In addition, platelet volume is defined as a marker of 
platelet activation and function, and is measured as 
MPV in the complete blood count (27). It is claimed that 
MPV increases in relation to thrombocytopenia in the 
acute phase of infection and decreases in the chronic 
phase associated with thrombocytosis (28). Therefore, 
MPV is also shown as an inflammatory marker and there 
are several studies showing the clinical benefit of MPV 
in various diseases such as malignancy, sepsis, 
thrombosis and even respiratory distress syndrome (28-
30). Some studies have examined the changes of MPV 
levels in infectious diseases (20-26). MPV levels were 
also found to have both increased and decreased in 
patients with Brucella, chronic hepatitis B and HIV (20-
25). In a study conducted by Hu et al. (20), a total of 120 
patients, including 17 with acute hepatitis B, 62 with 
chronic hepatitis B, and 41 with chronic severe hepatitis 
B, as well as 58 healthy controls, were evaluated. They 
demonstrated that MPV was significantly increased in 
chronic severe hepatitis B (12.3±0.8 fl) and chronic 
hepatitis B patients (11.7±1.2 fl), compared with healthy 
controls (10.5±0.9 fl) and acute hepatitis B patients 
(10.8±1.5 fl) (p<0.001). In another study conducted by 
Aydin et al. (24), the patients with brucellar epididymo-
orchitis were significantly more likely to have a lower 
MPV than those with non-brucellar epididymo-orchitis. 
Using a MPV cut-off level of less than 9.25 fl to 
differentiate brucellar from non-brucellar epididymo-
orchitis gives a sensitivity of 78.6%, a specificity of 
78.4%, a positive predictive value of 36.7%, and a 
negative predictive value of 95.8%. Although MPV was 
not significant in predicting abscess in our study, it was 
found to be significantly lower in granulomatous 
spondylodiscitis (8.9±1.2 fl) compared to pyogenic 
spondylodiscitis (9.5±1.1 fl) (p=0.016). MPV may be 
found lower in granulomatous spondylodiscitis in our 
study due to the more insidious progression and chronic 
course of granulomatous infections. 
 
Limitations of this study 
Our study has some limitations. A small number of 
patients was evaluated in the study. Because of the 
retrospective nature of our study, the biomarkers could 
not be assessed in terms of the predictability of acute 
spondylodiscitis in patients with back pain. 
Additionally, these biomarkers were evaluated only at 
the time of hospital admission; therefore, the follow-up 
and treatment response could not be analyzed.  
 
Spondylodiscitis as a public health problem 
Spondylodiscitis is a potentially devastating and rapidly 
progressing disease that may result in serious 
complications, such as vertebral collapse, abscess, 
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permanent neurologic deficits, or even death. Therefore, 
these infections have become an important clinical 
problem for public health that requires a serious medical 
and surgical approach. The prevalence and incidence of 
the disease has increased globally in the past 10 to 15 
years. The increasing age burden has been proposed as 
one of the main reasons for the rising incidence of 
spondylodiscitis. Therefore, it can be predicted that the 
incidence of spondylodiscitis will increase due to the 
aging of the world’s population in the coming years. In 
addition, Brucella and tuberculosis, which cause 
granulomatous spondylodiscitis, which is an important 
public health problem in many regions, especially in 
developing countries, is an important cause of morbidity 
and mortality. Spondylodiscitis is an important disease 
and health problem because of its potential morbidity 
and mortality; therefore, early diagnosis and effective 
antibiotherapy are crucial. It has been reported that 
spondylodiscitis has to be seen as a life-threatening 
condition and treated as an emergency. With the help of 
these simple laboratory tests, which are significant in 
demonstrating the etiology and the presence of abscess 
in spondylodiscitis in our study, the treatment process 




On the basis of our study, LMR was found to be useful 
in predicting abscess formation in patients with 
spondylodiscitis. In addition, both NLR and LMR can 
discriminate pyogenic and granulomatous etiology in 
patients with spondylodiscitis. These inflammatory 
biomarkers are simple, broadly available, cost-effective 
and promising parameters in spondylodiscitis. There is 
a need for further well-designed and prospective studies 
to examine the role of these biomarkers in 
spondylodiscitis. 
 
Funding: This research did not receive any specific 
grant from funding agencies in the public, commercial, 
or not-for-profit sectors.  
 
Authors’ contributions: PS designed the study, 
collected and analyzed data, and wrote the manuscript. 
TD designed the study, analyzed and interpreted the 
data, and reviewed and revised the manuscript. All 
authors approved the final version of the manuscript.  
 
Conflict of interest: All authors declare that they have 
no conflict of interest. 
 
References 
1. Lener S, Hartmann S, Barbagallo GMV, Certo 
F, Thomé C, Tschugg A. Management of 
spinal infection: A review of the literature. 
Acta Neurochir (Wien). 2018;160(3):487-96.  
2. Nickerson EK, Sinha R. Vertebral 
osteomyelitis in adults: An update. Br Med 
Bul. 2016;117(1):121-38. 
3. Tali ET. Spinal infection. Neuroimaging Clin 
N Am. 2015;25(2):xv. 
4. de Graeff JJ, Paulino Pereira NR, van Wulfften 
Palthe OD, Nelson SB, Schwab JH. Prognostic 
factors for failure of antibiotic treatment in 
patients with osteomyelitis of the spine. Spine 
(Phila Pa 1976). 2017;42(17):1339-46.  
5. Mavrogenis AF, Megaloikonomos PD, 
Igoumenou VG, Panagopoulos GN, 
Giannitsioti E, Papadopoulos A, et 
al.Spondylodiscitis revisited. EFORT Open 
Rev. 2017;2(11):447-61.  
6. Sağlam Aykut D, Civil Arslan F, Özkorumak 
Karagüzel E, Aral G, Karakullukçu S. The 
relationship between neutrophil-lymphocyte, 
platelet-lymphocyteratio and cognitive 
functions in bipolar disorder. Nord J 
Psychiatry. 2018;72(2):119-23.  
7. Huang Y, Ying Z, Quan W, Xiang W, Xie D, 
Weng Y, et al. The clinical significance of 
neutrophil-to-lymphocyteratio and monocyte-
to-lymphocyteratio in Guillain-Barré 
syndrome. Int J Neurosci. 2018(8):1-7.  
8. Salciccioli JD, Marshall DC, Pimentel MA, 
Santos MD,Pollard T,Celi LA,et al.The 
association between the neutrophil-to-
lymphocyte ratio and mortality in critical 
illness: An observational cohort study.Crit 
Care. 2015;19:13. 
9. Medzhitov R. Origin and physiological roles of 
inflammation. Nature. 2008;454(7203):428-
35.  
10. Pober JS, Sessa WC. Evolving functions of 
endothelial cells in inflammation. Nat Rev 
Immunol. 2007;7(10):803-15.  
11. Barton GM. A calculated response: Control of 
inflammation by the innate immune system. J 
Clin Invest. 2008;118(2):413-20.  
12. Serhan CN, Savill J. Resolution of 
inflammation: The beginning programs the 
end. Nat Immunol. 2005;6(12):1191-7.  
13. Drayton DL, Liao S, Mounzer RH, Ruddle NH. 
Lymphoid organ development: From ontogeny 
to neogenesis. Nat Immunol. 2006;7(4):344-
53.  
14. Hamiel U, Bahat H, Kozer E, Hamiel Y, Ziv-
Baran T, Goldman M. Diagnostic markers of 
acute infections in infants aged 1 week to 3 
months: A retrospective cohort study. BMJ 
Open. 2018;8(1):e018092.  
15. Peng J, Li H, Ou Q, Lin J, Wu X, Lu Z, et al. 
Preoperative lymphocyte-to-monocyteratio 
represents a superior predictor compared with 
neutrophil-to-lymphocyte and platelet-to-
lymphocyte ratios for colorectal liver-only 
metastases survival. Onco Targets Ther. 
2017;10:3789-99.  
16. Sen V, Bozkurt IH, Aydogdu O, Yonguc T, 
Yarimoglu S, Sen P, et al. Significance of 
preoperative neutrophil-lymphocyte count 
ratio on predicting postoperative sepsis after 
percutaneous nephrolithotomy. Kaohsiung J 
Med Sci. 2016;32(10):507-13.  
17. Naess A, Nilssen SS, Mo R, Eide GE, Sjursen 
H. Role of neutrophil to lymphocyte and 
monocyte to lymphocyte ratios in the diagnosis 
of bacterial infection in patients with fever. 
Infection. 2017;45(3):299-307.  
18. Zhao Z, Liu J, Wang J, Xie T, Zhang Q, Feng 
S, et al. Platelet-to-lymphocyte ratio (PLR) and 
neutrophil-to-lymphocyte ratio (NLR) are 
associated with chronic hepatitis B virus 
121     Ethiop. J. Health Dev. 
 
Ethiop. J. Health Dev.2020; 34(2) 
(HBV) infection. Int Immunopharmacol. 
2017;51:1-8.  
19. Meng X, Wei G, Chang Q, Peng R, Shi G, 
Zheng P, et al. The platelet-to-lymphocyte 
ratio, superior to the neutrophil-to-lymphocyte 
ratio, correlates with hepatitis C virus 
infection. Int J Infect Dis.2016;45:72-7.  
20. Hu Y, Lou Y, Chen Y, Mao W. Evaluation of 
mean platelet volume in patients with hepatitis 
B virus infection. Int J Clin Exp Med. 
2014;7(11):4207-13. 
21. Ceylan B, Mete B, Fincanci M, Aslan T, 
Akkoyunlu Y, Ozguneş N, et al. A new model 
using platelet indices to predict liver fibrosis in 
patients with chronic hepatitis B infection. 
Wien Klin Wochenschr. 2013;125(15-16):453-
60.  
22. Nkambule BB, Davison GM, Ipp H. The 
evaluation of platelet indices and markers of 
inflammation, coagulation and disease 
progression in treatment-naïve, asymptomatic 
HIV-infected individuals. Int J Lab Hematol. 
2015;37(4):450-8.  
23. Mena Á, Meijide H, Vázquez P, Castro Á, 
López S, Bello L, et al. HIV increases mean 
platelet volume during asymptomatic HIV 
infection in treatment-naive patients. J Acquir 
Immune DeficSyndr. 2011;57(5):e112-3.  
24. Aydin E, Karadag MA, Cecen K, Cigsar G, 
Aydin S, Demir A, et al. Association of mean 
platelet volume and the monocyte/lymphocyte 
ratio with brucella-caused epididymo-orchitis. 
Southeast Asian J Trop Med Public Health. 
2016;47(3):450-6. 
25. Aktar F, Tekin R, Bektaş MS, Güneş A, Köşker 
M, Ertuğrul S, et al. Diagnostic role of 
inflammatory markers in pediatric Brucella 
arthritis. Ital J Pediatr. 2016;42:3.  
26. Uslu AU, Aydin B, Balta S, Yonem O, Uncu T, 
Seven D. The effect of standard therapy on 
mean platelet volume in patients with chronic 
hepatitis C. Prz Gastroenterol. 2016;11(3):200-
5. 
27. Tajarernmuang P, Phrommintikul A, 
Limsukon A, Pothirat C, Chittawatanarat K. 
The role of mean platelet volume as a predictor 
of mortality in critically ill patients: A 
systematic review and meta-analysis. Crit Care 
Res Pract. 2016;2016:4370834.  
28. Robbins G, Barnard DL. Mean platelet volume 
changes in infection. J Clin Pathol. 
1983;36(11):1320.  
29. Zareifar S, Farahmand Far MR, Golfeshan F, 
Cohan N. Changes in platelet count and mean 
platelet volume during infectious and 
inflammatory disease and their correlation with 
ESR and CRP. J Clin Lab Anal. 
2014;28(3):245-8.  
30. Kalkan A, Memetoğlu ME, Bilir Ö, Ersunan G, 
Kutlu R, Tutar N. Is increased mean platelet 
volume a risk factor in patients with acute deep 
vein thrombosis? Tr J Emerg Med. 
2012;12(2):82-6. 
 
 
